ENDRA Life Sciences (NDRA) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts NDRA Hot Sheet
Join SI Premium – FREE
ENDRA Life Sciences (NASDAQ: NDRA) reported Q2 EPS of ($0.06), in-line with the analyst estimate of ($0.06).
For earnings history and earnings-related data on ENDRA Life Sciences (NDRA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ExxonMobil Q2 profit falls short of forecasts, shares slide
- Imperial Oil (IMO) Tops Q2 EPS by 19c
- Chevron beats estimates as oil prices surge, shares rise
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
